Search
START TYPING AND PRESS ENTER TO SEARCH

POLITICO: Revived rebate rule increases Medicare premiums, will not lower prescription drug costs for seniors

September 10, 2020

  • Highlights, Price OpEds

The Trump administration’s recent release of a series of drug pricing executive orders is leading to more questions than answers. While all four lack clear and sustainable pathways to reducing drug costs for all, the order to revive and finalize the so-called rebate rule – which the Administration proposed and then withdrew last year – is especially strange in its logic.

BACK TO PRESS RELEASES
BACK TO newsroom